Half-year report · HY
8938.TEDINET S100X4NM
Period2025-04-01 → 2025-09-30
Filed2025-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥993m | 2025-04-01 → 2025-09-30 | Cons. | Net sales |
| Revenue | ¥2.0bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥1.1bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Operating income | −¥37m | 2025-04-01 → 2025-09-30 | Cons. | Operating income |
| Operating income | ¥12m | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | −¥358m | 2025-04-01 → 2025-09-30 | Cons. | Ordinary income |
| Ordinary income | −¥53m | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥8m | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Profit before tax | −¥449m | 2025-04-01 → 2025-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥2m | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥449m | 2025-04-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥70m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥0 | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥449m | 2025-04-01 → 2025-09-30 | Cons. | Profit loss |
| Net income | ¥0 | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥8.0bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥8.6bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥8.4bn | at 2024-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥669m | at 2025-09-30 | Cons. | Liabilities |
| Total liabilities | ¥806m | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥7.4bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥7.8bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥7.8bn | at 2024-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.5bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.2bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.5bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.2bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.2bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.8bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥345m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥260m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥304m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | ¥642m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥366m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥335m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥24m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥43m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥49m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-49.72 | 2025-04-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥7.82 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-0.07 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 89.8% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 88.9% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 90.5% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 26
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2025-04-01 → 2025-09-30 | −¥212m |
| Medical Businessreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥929m |
| Medical Businessreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥929m |
| Medical Businessreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥152m |
| Real Estate Businessreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥64m |
| Real Estate Businessreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥64m |
| Real Estate Businessreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥21m |
| —segment total | revenue | 2025-04-01 → 2025-09-30 | ¥993m |
| —segment total | revenue external | 2025-04-01 → 2025-09-30 | ¥993m |
| —segment total | segment profit | 2025-04-01 → 2025-09-30 | ¥174m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-04-01 → 2025-09-30 | ¥993m |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-04-01 → 2025-09-30 | ¥993m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-04-01 → 2025-09-30 | ¥174m |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | −¥186m |
| Medical Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥1.0bn |
| Medical Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥1.0bn |
| Medical Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥180m |
| Real Estate Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥66m |
| Real Estate Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥66m |
| Real Estate Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥18m |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥1.1bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥1.1bn |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥199m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2024-09-30 | ¥1.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2024-09-30 | ¥1.1bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2024-09-30 | ¥199m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 519
| Item | Context | Value | Unit |
|---|---|---|---|
| Retirement benefit expenses sga | Prior1InterimDuration | 2000000 | JPY |
| Retirement benefit expenses sga | InterimDuration | 2000000 | JPY |
| Welfare expenses sga | Prior1InterimDuration | 40000000 | JPY |
| Welfare expenses sga | InterimDuration | 42000000 | JPY |
| Depreciation sga | Prior1InterimDuration | 8000000 | JPY |
| Depreciation sga | InterimDuration | 7000000 | JPY |
| Goodwill amortization sga | Prior1InterimDuration | 8000000 | JPY |
| Goodwill amortization sga | InterimDuration | 8000000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E04034-000MedicalBusinessReportableSegmentsMember | 1007000000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E04034-000RealEstateBusinessReportableSegmentsMember | 66000000 | JPY |
| Revenues from external customers | Prior1InterimDuration_ReportableSegmentsMember | 1074000000 | JPY |
| Revenues from external customers | Prior1InterimDuration_TotalOfReportableSegmentsAndOthersMember | 1074000000 | JPY |
| Revenues from external customers | Prior1InterimDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1InterimDuration | 1074000000 | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E04034-000MedicalBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E04034-000RealEstateBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1InterimDuration_ReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1InterimDuration_TotalOfReportableSegmentsAndOthersMember | － | JPY |
| Transactions with other segments | Prior1InterimDuration_ReconcilingItemsMember | － | JPY |
| Transactions with other segments | Prior1InterimDuration | － | JPY |
| Net sales | Prior1InterimDuration_jpcrp040300-ssr_E04034-000MedicalBusinessReportableSegmentsMember | 1007000000 | JPY |
| Net sales | Prior1InterimDuration_jpcrp040300-ssr_E04034-000RealEstateBusinessReportableSegmentsMember | 66000000 | JPY |
| Net sales | Prior1InterimDuration_ReportableSegmentsMember | 1074000000 | JPY |
| Net sales | Prior1InterimDuration_TotalOfReportableSegmentsAndOthersMember | 1074000000 | JPY |
| Net sales | Prior1InterimDuration_ReconcilingItemsMember | － | JPY |
| Net sales | Prior1InterimDuration | 1074000000 | JPY |
| Operating income | Prior1InterimDuration_jpcrp040300-ssr_E04034-000MedicalBusinessReportableSegmentsMember | 180000000 | JPY |
| Operating income | Prior1InterimDuration_jpcrp040300-ssr_E04034-000RealEstateBusinessReportableSegmentsMember | 18000000 | JPY |
| Operating income | Prior1InterimDuration_ReportableSegmentsMember | 199000000 | JPY |
| Operating income | Prior1InterimDuration_TotalOfReportableSegmentsAndOthersMember | 199000000 | JPY |
| Operating income | Prior1InterimDuration_ReconcilingItemsMember | -186000000 | JPY |
| Operating income | Prior1InterimDuration | 12000000 | JPY |
| Revenues from external customers | InterimDuration_jpcrp040300-ssr_E04034-000MedicalBusinessReportableSegmentsMember | 929000000 | JPY |
| Revenues from external customers | InterimDuration_jpcrp040300-ssr_E04034-000RealEstateBusinessReportableSegmentsMember | 64000000 | JPY |
| Revenues from external customers | InterimDuration_ReportableSegmentsMember | 993000000 | JPY |
| Revenues from external customers | InterimDuration_TotalOfReportableSegmentsAndOthersMember | 993000000 | JPY |
| Revenues from external customers | InterimDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | InterimDuration | 993000000 | JPY |
| Transactions with other segments | InterimDuration_jpcrp040300-ssr_E04034-000MedicalBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | InterimDuration_jpcrp040300-ssr_E04034-000RealEstateBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | InterimDuration_ReportableSegmentsMember | － | JPY |
| Transactions with other segments | InterimDuration_TotalOfReportableSegmentsAndOthersMember | － | JPY |
| Transactions with other segments | InterimDuration_ReconcilingItemsMember | － | JPY |
| Transactions with other segments | InterimDuration | － | JPY |
| Net sales | InterimDuration_jpcrp040300-ssr_E04034-000MedicalBusinessReportableSegmentsMember | 929000000 | JPY |
| Net sales | InterimDuration_jpcrp040300-ssr_E04034-000RealEstateBusinessReportableSegmentsMember | 64000000 | JPY |
| Net sales | InterimDuration_ReportableSegmentsMember | 993000000 | JPY |
| Net sales | InterimDuration_TotalOfReportableSegmentsAndOthersMember | 993000000 | JPY |
| Net sales | InterimDuration_ReconcilingItemsMember | － | JPY |
| Net sales | InterimDuration | 993000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |